Vanguard Group Inc Soleno Therapeutics Inc Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.16 - $2.48 $325,728 - $5.05 Million
-2,035,806 Closed
0 $0
Q2 2022

Aug 12, 2022
SELL
$0.14 - $0.23 $2,246 - $3,690
-16,045 Reduced 0.78%
2,035,806 $377,000
Q1 2022

May 13, 2022
SELL
$0.22 - $0.47 $2,759 - $5,894
-12,541 Reduced 0.61%
2,051,851 $457,000
Q4 2021

Feb 14, 2022
SELL
$0.41 - $0.91 $1,689 - $3,749
-4,120 Reduced 0.2%
2,064,392 $846,000
Q2 2021

Aug 13, 2021
BUY
$0.97 - $1.32 $2.01 Million - $2.73 Million
2,068,512 New
2,068,512 $2.36 Million

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $441M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email